PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
Clinical trial NCT05928039 · RECRUITING
Trial details
- NCT number
- NCT05928039
- Sponsor
- University of Calgary
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2027-07-30
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.